ストックスクリーナーアプリを入手
32.19
0.00%
0.00
プレマーケット:
32.55
0.36
+1.12%
前日終値:
$32.19
開ける：
$32.57
24時間の取引高:
2.55M
Relative Volume:
0.57
時価総額：
$14.07B
収益：
$2.27B
当期純損益:
$1.15B
株価収益率:
12.62
EPS:
2.55
ネットキャッシュフロー:
$2.80B
1週間 パフォーマンス:
-0.80%
1か月 パフォーマンス:
-4.48%
6か月 パフォーマンス:
+17.61%
1年 パフォーマンス:
+15.71%
1日の値動き範囲:
$31.97
$32.73
1週間の範囲:
$31.97
$32.73
52週間の値動き範囲:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
32.19 | 14.07B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.47 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.49 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
599.87 | 36.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.75 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
252.77 | 25.74B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Cerity Partners LLC Reduces Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Guggenheim Capital LLC Cuts Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Raymond James Financial Inc. Invests $19.99 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Evergreen Capital Management LLC - MarketBeat
Sterling Capital Management LLC Raises Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Treasurer of the State of North Carolina Sells 10,837 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Keeps Dividend at $0.22 A Share, Payable June 10 to Shareholders of Record May 16 - marketscreener.com
Royalty Pharma plc Announces Second Quarter 2025 Dividend Payment of $0.22 per Class A Ordinary Share - Nasdaq
Royalty Pharma Declares Second Quarter 2025 Dividend - The Manila Times
Royalty Pharma Q2 2025 Dividend: $0.22 Per Share Payable June 10Key Dates and Details - Stock Titan
Bank of Montreal Can Has $3.69 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
BofA Adjusts Price Target on Royalty Pharma to $42 From $41 - marketscreener.com
Bridgewater Associates LP Purchases Shares of 49,416 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Jump Financial LLC Acquires Shares of 81,855 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Invesco Ltd. Has $24.44 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Ontario Teachers Pension Plan Board Sells 10,748 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Synovus Financial Corp Has $483,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Portolan Capital Management LLC Purchases 173,721 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Regal Investment Advisors LLC Decreases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Royalty Pharma plc to Announce Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Royalty Pharma Schedules Critical Q1 2025 Earnings Release: Key Details for Investors - Stock Titan
Legal & General Group Plc Has $67.19 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management N.V. Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Aviva PLC Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management US Inc. Takes $201,000 Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by CenterBook Partners LP - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Fmr LLC - MarketBeat
Russell Investments Group Ltd. Buys 449,551 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
ADAR1 Capital Management LLC Sells 1,046,703 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Franklin Resources Inc. Sells 921,034 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
JPMorgan Chase & Co. Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma modifies acquisition agreement By Investing.com - Investing.com South Africa
Royalty Pharma modifies acquisition agreement - Investing.com
ExodusPoint Capital Management LP Invests $3.66 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Prudential PLC - MarketBeat
Headlands Technologies LLC Has $115,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Geode Capital Management LLC Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know - Yahoo Finance
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Position Cut by Rhenman & Partners Asset Management AB - MarketBeat
Integrated Quantitative Investments LLC Buys New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Enters Oversold Territory - Nasdaq
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
2.49%
大文字化:
|
ボリューム (24 時間):